NASDAQ: LXRX. Lexicon's Common Stock. Last price ... Investor Relations lexinvest@lexpharma.com. Media ... Report a ConcernAdverse Event ReportingPricing ...
People also ask
Is LXRX a good buy?
Why is LXRX stock dropping?
What are the predictions for LXRX?
When did the FDA approve LXRX?
NASDAQ: LXRX. Lexicon's Common Stock. Last price. $1.82. Change today. -2.67%. Investor Relations ... Report a ConcernAdverse Event ReportingPricing Disclosures.
Lexicon Pharmaceuticals, Inc. Common Stock is estimated to report earnings on 05/07/2024. The upcoming earnings date is derived from an algorithm based on a ...
LXRX on Nasdaq. This company's Exchange Act ... [+] 10-K (annual reports) and 10-Q (quarterly reports) ... Before you Invest, Investor.gov. Get answers to your ...
Apr 11, 2018 · Seeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects.
Missing: relations | Show results with:relations
Get the latest insights on Lexicon Pharmaceuticals, Inc. Common Stock (LXRX) with press releases and corporate news to help you in your trading and ...
Head of Investor Relations & Corporate Strategy, N/A, N/A, 1980. Mr. Dixon Terry, Vice President of Compliance, N/A, N/A, N/A. Ms. Carrie Siragusa, Vice ...
Investor Relations URL, N/A. HQ State/Province, Texas. Sector, Healthcare. Industry, Biotechnology. Equity Style, Small Cap/Blend. Next Earnings Release, May.
Lexicon Pharmaceuticals, Inc. (US:LXRX) has 221 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission ...
Access Lexicon Pharmaceuticals Inc (LXRX) Investor Relations material, such as Live Earnings Calls, Transcripts, Slides, Reports, and Estimates using ...